These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 15961575)
1. Effect of plasmid backbone modification by different human CpG motifs on the immunogenicity of DNA vaccine vectors. Coban C; Ishii KJ; Gursel M; Klinman DM; Kumar N J Leukoc Biol; 2005 Sep; 78(3):647-55. PubMed ID: 15961575 [TBL] [Abstract][Full Text] [Related]
2. Plasmids enriched with CpG motifs activate human peripheral blood mononuclear cells in vitro and enhance th-1 immune responses to hepatitis B surface antigen in mice. Chen Z; Cao J; Liao X; Ke J; Zhu S; Zhao P; Qi Z Viral Immunol; 2011 Jun; 24(3):199-209. PubMed ID: 21668361 [TBL] [Abstract][Full Text] [Related]
3. Characteristics of oligodeoxyribonucleotides that induce interferon (IFN)-alpha in the pig and the phenotype of the IFN-alpha producing cells. Domeika K; Magnusson M; Eloranta ML; Fuxler L; Alm GV; Fossum C Vet Immunol Immunopathol; 2004 Sep; 101(1-2):87-102. PubMed ID: 15261695 [TBL] [Abstract][Full Text] [Related]
4. Adjuvant effect of multi-CpG motifs on an HIV-1 DNA vaccine. Kojima Y; Xin KQ; Ooki T; Hamajima K; Oikawa T; Shinoda K; Ozaki T; Hoshino Y; Jounai N; Nakazawa M; Klinman D; Okuda K Vaccine; 2002 Jul; 20(23-24):2857-65. PubMed ID: 12126895 [TBL] [Abstract][Full Text] [Related]
5. Immunostimulatory capacity of DNA vaccine vectors in porcine PBMC: a specific role for CpG-motifs? Verfaillie T; Cox E; Goddeeris BM Vet Immunol Immunopathol; 2005 Jan; 103(1-2):141-51. PubMed ID: 15626469 [TBL] [Abstract][Full Text] [Related]
6. CpG DNA augments the immunogenicity of plasmid DNA vaccines. Klinman DM; Ishii KJ; Verthelyi D Curr Top Microbiol Immunol; 2000; 247():131-42. PubMed ID: 10689784 [No Abstract] [Full Text] [Related]
7. CpG-A oligonucleotides induce a monocyte-derived dendritic cell-like phenotype that preferentially activates CD8 T cells. Krug A; Rothenfusser S; Selinger S; Bock C; Kerkmann M; Battiany J; Sarris A; Giese T; Speiser D; Endres S; Hartmann G J Immunol; 2003 Apr; 170(7):3468-77. PubMed ID: 12646607 [TBL] [Abstract][Full Text] [Related]
8. Three types of human CpG motifs differentially modulate and augment immunogenicity of nonviral and viral replicon DNA vaccines as built-in adjuvants. Yu YZ; Li N; Ma Y; Wang S; Yu WY; Sun ZW Eur J Immunol; 2013 Jan; 43(1):228-39. PubMed ID: 23037552 [TBL] [Abstract][Full Text] [Related]
9. Immunostimulatory effects of plasmid DNA and synthetic oligodeoxynucleotides. Zelenay S; Elías F; Fló J Eur J Immunol; 2003 May; 33(5):1382-92. PubMed ID: 12731065 [TBL] [Abstract][Full Text] [Related]
10. CpG-A-induced monocyte IFN-gamma-inducible protein-10 production is regulated by plasmacytoid dendritic cell-derived IFN-alpha. Blackwell SE; Krieg AM J Immunol; 2003 Apr; 170(8):4061-8. PubMed ID: 12682235 [TBL] [Abstract][Full Text] [Related]
11. Augmentation of cellular immune responses to bovine herpesvirus-1 glycoprotein D by vaccination with CpG-enhanced plasmid vectors. Pontarollo RA; Babiuk LA; Hecker R; van Drunen Littel-van den Hurk S J Gen Virol; 2002 Dec; 83(Pt 12):2973-2981. PubMed ID: 12466473 [TBL] [Abstract][Full Text] [Related]
13. Immunostimulatory CpG-modified plasmid DNA enhances IL-12, TNF-alpha, and NO production by bovine macrophages. Shoda LK; Kegerreis KA; Suarez CE; Mwangi W; Knowles DP; Brown WC J Leukoc Biol; 2001 Jul; 70(1):103-12. PubMed ID: 11435492 [TBL] [Abstract][Full Text] [Related]
14. Immunostimulatory DNA activates production of type I interferons and interleukin-6 in equine peripheral blood mononuclear cells in vitro. Wattrang E; Berg M; Magnusson M Vet Immunol Immunopathol; 2005 Sep; 107(3-4):265-79. PubMed ID: 15955566 [TBL] [Abstract][Full Text] [Related]
15. Contribution of CpG motifs to the immunogenicity of DNA vaccines. Klinman DM; Yamshchikov G; Ishigatsubo Y J Immunol; 1997 Apr; 158(8):3635-9. PubMed ID: 9103425 [TBL] [Abstract][Full Text] [Related]
16. Induction of interleukin-6 and interleukin-12 in bovine B lymphocytes, monocytes, and macrophages by a CpG oligodeoxynucleotide (ODN 2059) containing the GTCGTT motif. Zhang Y; Shoda LK; Brayton KA; Estes DM; Palmer GH; Brown WC J Interferon Cytokine Res; 2001 Oct; 21(10):871-81. PubMed ID: 11711000 [TBL] [Abstract][Full Text] [Related]
17. Rational design of new CpG oligonucleotides that combine B cell activation with high IFN-alpha induction in plasmacytoid dendritic cells. Hartmann G; Battiany J; Poeck H; Wagner M; Kerkmann M; Lubenow N; Rothenfusser S; Endres S Eur J Immunol; 2003 Jun; 33(6):1633-41. PubMed ID: 12778481 [TBL] [Abstract][Full Text] [Related]
18. Enhanced tumor-specific long-term immunity of hemagglutinating [correction of hemaggluttinating] virus of Japan-mediated dendritic cell-tumor fused cell vaccination by coadministration with CpG oligodeoxynucleotides. Hiraoka K; Yamamoto S; Otsuru S; Nakai S; Tamai K; Morishita R; Ogihara T; Kaneda Y J Immunol; 2004 Oct; 173(7):4297-307. PubMed ID: 15383558 [TBL] [Abstract][Full Text] [Related]
19. Immunoadjuvant efficacy of plasmids with multiple copies of a CpG motif coadministrated with avian influenza vaccine in chickens. Hung LH; Tsai PC; Wang CH; Li SL; Huang CC; Lien YY; Chaung HC Vaccine; 2011 Jun; 29(29-30):4668-75. PubMed ID: 21557981 [TBL] [Abstract][Full Text] [Related]
20. Bacterial DNA and immunostimulatory CpG oligonucleotides trigger maturation and activation of murine dendritic cells. Sparwasser T; Koch ES; Vabulas RM; Heeg K; Lipford GB; Ellwart JW; Wagner H Eur J Immunol; 1998 Jun; 28(6):2045-54. PubMed ID: 9645386 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]